Podcasts about cells

ReferencesProtein Cel l 2018. 9, 196–206 J Biol Chem. 2012 Nov 23;287(48):40131-9Biol Sex Differ. 2023 Sep 28;14:66J Biol Chem. 2012 May18;287(21):17589-17597PLoS Biol 2014. 12(10): e1001969. Cells.2020 Dec 16;9(12):2697. Int Rev Cell Mol Biol. 2016:325:215-73Redox Biology 2021. 47, November 102165Richards/Jagger. 19 75. "Wild Horses"https://music.youtube.com/watch?v=nY_GgPi5eCM&si=QFvbe-4tXX_8WqoFLamm, R. 1969. Beginnings, Chicagohttps://music.youtube.com/watch?v=lI-BMDnti4c&si=fHHMO-NwVEB5NSo9Lamm, R. 1971. "Free"https://music.youtube.com/watch?v=5VK77V4hWTo&si=pgRZYVfjGwF65BQKLamm, R.1971. "At the Sunrise"https://music.youtube.com/watch?v=o_X909h1x1k&si=3HMv6gS9Mf0mGLRM

The promise of advanced cell therapies is undeniable, but as demand skyrockets, the challenges of taking a living drug from bench to bedside have never been greater. Each batch brings variability, each jurisdiction adds regulatory hurdles, and every strategic decision can determine whether a lifesaving therapy reaches patients or fizzles out behind clinical barriers.Lindsay Davies is a leading figure in the cell and gene therapy field, serving as Vice President-Elect for Europe at the International Society of Cell and Gene Therapy (ISCT). She is Chief Scientific Officer at NextCell Pharma, co-founder of QVance, and founder of the consultancy CellTherEx. With over 20 years of experience across academia and industry, she brings deep expertise in MSC manufacturing, process development, and commercialization of advanced therapies. Here are three reasons this episode is a must-listen:Manufacturing at Scale, Without Compromise: Lindsay shares why NextCell Pharma has stuck with large-scale 2D manufacturing for MSCs, leveraging cell morphology and a patented donor selection algorithm to reduce batch-to-batch variability while maximizing reproducibility and safety, even when treating hundreds from a single batch.Smart Scaling: Up, Out, or Both? The debate isn't just academic. Lindsay explores when it makes sense to scale up processes versus scaling out to multiple manufacturing sites. She highlights how harmonizing global regulatory expectations and moving to closed 2D systems can lower costs, de-risk production, and bring life-changing therapies to more patients worldwide.Network or Nowhere: Lindsay calls out the myth of the lone innovator, championing the crucial role of strategic networking, partnership models, including “sweat equity”, and early regulatory engagement as keys to avoiding the common commercialization pitfalls that stall so many promising ATMPs.Wondering how to navigate the twin challenges of process control and commercial viability in ATMP development? This episode offers a rare, candid roadmap from the front lines.Connect with Lindsay Davis:LinkedIn: www.linkedin.com/in/lindsay-c-daviesWebsite: www.nextcellpharma.comIf you're interested in breakthroughs in cell therapy, here's what some of our previous guests have shared from the front lines of innovation:Episodes 105-106: From Proteins to Cell Therapy: Why ATMPs Aren't Just Complex Biologics with Oliver KraemerEpisodes 109-110: Spinning Like Earth: Designing Low-Shear Bioreactors for Better Cell Culture with Olivier DetournayEpisodes 125-126: How to Enhance Cell Engineering Using Mechanical Intracellular Delivery with Armon ShareiNext step:Book a free consultation to help you get started on any questions you may have about bioprocess development: https://bruehlmann-consulting.com/call

The key to conquering autoimmune diseases and type 1 diabetes may lie not in replacing lost cells, but in retraining the immune system using cells already within the body.Biotech is increasingly exploring stem cell therapies, but a quieter revolution is brewing: stromal cell therapy. These master “coordinators” aren't about rebuilding tissues molecule by molecule - instead, they orchestrate an anti-inflammatory response, offering new hope for conditions once considered incurable.In this episode of the Smart Biotech Scientist Podcast, host David Brühlmann speaks with Lindsay Davies, a leading expert in advanced therapies. She is the CSO at NextCell Pharma, consultant at CellTherEx, and co-founder of QVance, a QC analytics provider for ATMPs. Recently elected Vice President Elect for Europe at ISCT, Lindsay also chairs its European Industry Committee and serves on multiple task forces. With over 20 years bridging academia and industry, she's helped shape the full lifecycle of cell-based therapies, from development to commercialization.Here are three reasons why you can't miss this episode:Stromal Cells - The Unsung Heroes: Discover the essential distinction between stem cells (the “builders”) and stromal cells (the “coordinators”), and how harnessing the latter's unique immune-modulatory powers is unlocking treatments for diabetes, COVID-19, and autoimmune diseases.A Manufacturing Mindset Shift: Lindsay explains why scaling out cell therapies defies the “plug-and-play” approaches of traditional biologics manufacturing. With cell quality so sensitive to environmental shifts, the key lies in process simplicity, early regulatory collaboration, and deep biological understanding - especially when donor variability enters the mix.Allogeneic Therapies Made Real: Thanks to umbilical cord-derived stromal cells, treatments can be manufactured at scale, stored frozen, and delivered on demand - no patient matching required. The result? Outpatient infusions, no side effects, and effects lasting up to five years, dramatically simplifying lives for those with chronic inflammatory conditions.Ready to rethink how cell therapies are changing medicine - and what it could mean for your bioprocessing strategy? Hit play and find out how Lindsay Davis is redefining what's possible in advanced therapy manufacturing.Connect with Lindsay Davis:LinkedIn: www.linkedin.com/in/lindsay-c-daviesWebsite: www.nextcellpharma.comIf you're interested in breakthroughs in cell therapy, here's what some of our previous guests have shared from the front lines of innovation:Episodes 105-106: From Proteins to Cell Therapy: Why ATMPs Aren't Just Complex Biologics with Oliver KraemerEpisodes 109-110: Spinning Like Earth: Designing Low-Shear Bioreactors for Better Cell Culture with Olivier DetournayEpisodes 125-126: How to Enhance Cell Engineering Using Mechanical Intracellular Delivery with Armon ShareiNext step:Book a free consultation to help you get started on any questions you may have about bioprocess development: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest anJoin 500+ CGT leaders at Advanced Therapies Europe 2025 (September 2-4, Barcelona) for live case studies, regulatory insights, and exclusive collaboration opportunities. As a Smart Biotech Scientist listeners you'll save 20% with code SMARTPODCAST20 – Register hereSupport the show

Topics:  In this bonus episode, Brant talks about what he's learning from the book: "The Matter With Things" by Iain McGilchrist. Including: - Exploring the complexity and intelligence of living cells. - Challenging purely mechanical views of biology. - Why relationships and context are paramount.   And most importantly…   The many spiritual parallels that can be derived from the book and how who we are becoming matters way more than our past.     Quotes: “Life requires cognition at all levels. Our cells think!” “Genes do nothing on their own; life is far more than DNA.” “Flatworms can regrow their brains and still remember.” “Healing is God's work; medicine cooperates with it.” . . . Holy Ghost Mama Pre-Order! Want more of the Oddcast? Check out our website! Watch our YouTube videos here. Connect with us on Facebook! For Christian banking you can trust, click here!

Seit 65 Jahren ist die Pille auf dem Markt. Ein vergleichbares Verhütungsmittel für den Mann gibt es bisher nicht. Das soll sich jetzt ändern. Weltweit arbeiten Forschende daran, ein sicheres und bequem zu nutzendes männliches Verhütungsmittel zu entwickeln. In dieser Podcast Folge fragt unsere Reporterin Daniela Remus: Wo steht die Forschung aktuell? Credits: Autorin/Sprecherin: Daniela Remus Redaktion: Iska Schreglmann Unsere GesprächspartnerInnen: Prof. Arthur Mayerhofer, Androloge, Ludwig-Maximilians-Universität München https://www.med.lmu.de/de/fakultaet/wer-wir-sind/personen/kontaktseite/artur-mayerhofer-29a123ea.html Jana Pfenning, Politikwissenschaftlerin, Better Birth Control, Berlin https://betterbirthcontrol.org/about Prof. Hubert Schorle, Keimzellforscher und Pathologe, Universität Bonn https://www.uni-bonn.de/de/forschung-lehre/forschungsprofil/transdisziplinaere-forschungsbereiche/tra-3-life-1/mitgliederverzeichnis/hubert-schorle Prof. Armin Soave, Androloge, Universitätsklinikum Eppendorf, Hamburg https://www.uke.de/allgemein/arztprofile-und-wissenschaftlerprofile/arztprofilseite_armin_soave.html Prof. Timo Strünker, Molekularbiologe, Universität Münster https://www.uni-muenster.de/Cells-in-Motion/de/people/all/struenker-t.php Prof. Michael Zitzmann, Androloge, Universität Münster https://www.ukm.de/kliniken/andrologie/team Zum Weiterhören: Warum haben wir immer weniger Sex? https://www.ardaudiothek.de/episode/urn:ard:episode:5a1d4b1ecb5ddedc/ Zum Weiterlesen und Quellen: Laufende Studie in den USA für ein nicht-hormonelles Verhütungsmittel für den Mann: https://www.nature.com/articles/s43856-025-01004-4 Wir freuen uns über Post von Euch: WhatsApp (https://wa.me/491746744240) oder iq@br.de Falls Euch der IQ-Podcast gefällt, freuen wir uns über eine gute Bewertung, einen freundlichen Kommentar und ein Abo. Und wenn Ihr unseren Podcast unterstützen wollt, empfehlt uns gerne weiter! IQ verpasst? Hier könnt ihr die letzten Folgen hören: https://1.ard.de/IQWissenschaft

Send us a textThe Resonant Body Podcast Series | Exploring Energy Medicine, Frequency & HealingWelcome to The Resonant Body, a three-part podcast series hosted by Dr. Michelle Greenwell, PhD CIH BioEW, featuring energy medicine expert Dr. Christina Ross, PhD. Dive deep into the science and spirit of subtle energy and discover how it shapes our health from the cellular level to whole-body regeneration.About the Series:This trilogy explores the intersection of biophysics, quantum healing, and vibrational medicine to illuminate new pathways for empowered self-care and holistic wellness. Each episode is paired with a specially curated tea from the Cape Breton Tea Company, blending science, ritual, and intention.Episode 1: The Biophysics of Energy Medicine: How Subtle Energy Affects Cellular and Molecular FunctionIn this first episode, we explore how subtle energy modulates cellular communication and molecular function to support whole-person well-being. Learn how cells respond not only to biochemical signals but also to energetic frequencies, opening doors to proactive, preventive self-care before symptoms arise.Featuring the comforting Marvelous Miss Maple tea, this episode invites you to savor the sweetness of life and the healing power of energy medicine.

Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.

There are many groups in the United States that are meeting and planning how to respond to the Trump presidency. They are breying about DEMOCRACY while planning to upend the outcomes of an election.Worse then that they are planning a campaign of non compliance.Are you prepared for what America could look like? I find this very interesting considering we are doing our CIVIL WAR 2.0 Continuity meeting this month. Be sure to join us on the Members side. Join below.www.pbnfamily.comwww.limatangosurvival.comwww.packfreshusa.comDONATE https://bit.ly/3SICxEq

It's no secret that stress isn't good for you. But just how bad is it? Well, in the last few decades, scientists have linked psychological stress to changes in our DNA that look a lot like what happens on the molecular level as we age. Today on the show, host Regina G. Barber talks to freelance science journalist Diana Kwon about the latest research on stress and aging, including a new hypothesis for how your brain handles aging — and what science could do about all of it.Interested in more aging science? Let us know at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

In this episode Dr Sarah Howard discusses healthy ageing in dogs with Dr Matthew Muir. Topics discussed include: The reason ageing is currently a hot topic. What leads to an increased lifespan and better quality of life? Diet changes that can impact ageing in dogs. Dr Muir discusses what we should avoid in order to increase lifespan. Matthew goes into details of what dogs' diets should look like to prevent disease. How often should we be feeding our pets? What happens to the gut microbiome as dogs get older? Dr Muir delves into supplements that can be beneficial for ageing and emerging tools that are becoming available. The importance of preventative medicine - proactive vs reactive care. Accelerators of biological ageing. Additional resources: https://pubmed.ncbi.nlm.nih.gov/11991408/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11675035/https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2024.1355560/full https://pmc.ncbi.nlm.nih.gov/articles/PMC11505706/ https://www.mdpi.com/1660-3397/18/11/564https://pmc.ncbi.nlm.nih.gov/articles/PMC4936929/ https://pubmed.ncbi.nlm.nih.gov/22216092/ Adams VJ, Watson P, Carmichael S, Gerry S, Penell J, Morgan DM. Exceptional longevity and potential determinants of successful ageing in a cohort of 39 Labrador retrievers: results of a prospective longitudinal study. Acta Vet Scand. 2016;58:29. doi:10.1186/s13028-016-0204-8 Cupp CJ, Jean-Philippe C, Kerr WW, Patil AR. Effect of nutritional interventions on longevity of senior cats. Int J Appl Res Vet Med. 2007;5(3):133–149 Bermingham EN, Patterson KA, Shoveller AK, Fraser K, Butowski CF, Thomas DG. Nutritional needs and health outcomes of ageing cats and dogs: is it time for updated nutrient guidelines? Anim Front. 2024;14(3):5–16. doi:10.1093/af/vfae008 Jackson J, Radford AD, Belshaw Z, Wallis LJ, Kubinyi E, German AJ, Westgarth C. Using veterinary health records at scale to investigate ageing dogs and their common issues in primary care. J Small Anim Pract. 2025;66(2):81–91. doi:10.1111/jsap.13809 Creevy KE, O'Neill DG, Promislow DEL. Morbidity and mortality in elderly dogs – a model for human aging. BMC Vet Res. 2022;18(1):456. doi:10.1186/s12917-022-03518-8 Lewis TW, Wiles BM, Llewellyn-Zaidi AM, Evans KM, O’Neill DG. Longevity and mortality in Kennel Club registered dog breeds in the UK in 2014. Canine Genet Epidemiol. 2018;5:10. doi:10.1186/s40575-018-0066-8 Kealy RD, Lawler DF, Ballam JM, Mantz SL, Biery DN, Greeley EH, Lust G, Segre M, Smith GK, Stowe HD. Effects of diet restriction on life span and age-related changes in dogs. J Am Vet Med Assoc. 2002;220(9):1315–1320. doi:10.2460/javma.2002.220.1315 Guelfi G, Capaccia C, Tedeschi M, Bufalari A, Leonardi L, Cenci-Goga B, Maranesi M. Dog aging: a comprehensive review of molecular, cellular, and physiological processes. Cells. 2024;13(24):2101. doi:10.3390/cells13242101 Laflamme DP. Nutritional care for aging cats and dogs. Vet Clin North Am Small Anim Pract. 2012;42(4):769–791. doi:10.1016/j.cvsm.2012.04.002 Hall JA, Jewell DE. Feeding healthy beagles medium-chain triglycerides, fish oil, and L-carnitine offsets age-related changes in serum fatty acids and carnitine metabolites. PLoS One. 2012;7(11):e49510. doi:10.1371/journal.pone.0049510 Bermingham EN, Patterson KA, Shoveller AK, Fraser K, Butowski CF, Thomas DG. Nutritional needs and health outcomes of ageing cats and dogs: is it time for updated nutrient guidelines? Anim Front. 2024;14(3):5–16. doi:10.1093/af/vfae008 Bray EE, Zheng Z, Tolbert MK, McCoy BM, Kaeberlein M, Kerr KF; Dog Aging Project Consortium. Once-daily feeding is associated with better health in companion dogs: results from the Dog Aging Project. GeroScience. 2022;44(3):1779–1790. doi:10.1007/s11357-022-00575-7 Palaseweenun P, Hagen‐Plantinga EA, Schonewille JT, Koop G, Butre C, Jonathan M, Wierenga PA, Hendriks WH. Urinary excretion of advanced glycation end products in dogs and cats. J Anim Physiol Anim Nutr (Berl). 2021;105(1):149–156. doi:10.1111/jpn.13347 Yang L, Yang L, Cai Y, Luo Y, Wang H, Wang L, Chen J, Liu X, Wu Y, Qin Y, Wu Z, Liu N. Natural mycotoxin contamination in dog food: a review on toxicity and detoxification methods. Ecotoxicol Environ Saf. 2023;257:114948. doi:10.1016/j.ecoenv.2023.114948 Bridglalsingh S, Archer-Hartmann S, Azadi P, Barbier de La Serre C, Remillard RL, Sunvold GD, Bartges JW. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs. J Anim Physiol Anim Nutr (Berl). 2024;108(3):735–751. doi:10.1111/jpn.13927 Marchi PH, Vendramini THA, Perini MP, Zafalon RVA, Amaral AR, Ochamotto VA, Da Silveira JC, Dagli MLZ, Brunetto MA. Obesity, inflammation, and cancer in dogs: review and perspectives. Front Vet Sci. 2022;9:1004122. doi:10.3389/fvets.2022.1004122 Schmid SM, Hoffman JM, Prescott J, Ernst H, Promislow DEL, Creevy KE; Dog Aging Project Consortium. The companion dog as a model for inflammaging: a cross-sectional pilot study. GeroScience. 2024;46(6):5395–5407. doi:10.1007/s11357-024-01217-w Ren J, Li H, Zeng G, Pang B, Wang Q, Wei J. Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time? Front Pharmacol. 2023;14:1178596. doi:10.3389/fphar.2023.1178596 Parker A, Romano S, Ansorge R, Aboelnour A, Le Gall G, Savva GM, Pontifex MG, Telatin A, Baker D, Jones E, Vauzour D, Rudder S, Blackshaw LA, Jeffery G, Carding SR. Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain. Microbiome. 2022;10:68. doi:10.1186/s40168-022-01262-3 Ulluwishewa D, Anderson RC, McNabb WC, et al. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 2011;141(5):769–76. doi:10.3945/jn.110.135657 Cao L, Lee SG, Lim KT, Kim HR. Potential anti-aging substances derived from seaweeds. Mar Drugs. 2020;18(11):564. doi:10.3390/md18110564 Grzeczka A, Graczyk S, Kordowitzki P. Pleiotropic effects of resveratrol on aging-related cardiovascular diseases—what can we learn from research in dogs? Cells. 2024;13(20):1732. doi:10.3390/cells13201732 Kusaba A, Arai T. Shiitake mushroom powder supplementation increases antioxidative activity in dogs. Front Vet Sci. 2024;11:1355560. doi:10.3389/fvets.2024.1355560 Cho HW, Choi S, Seo K, Kim KH, Jeon JH, Kim CH, Lim S, Jeong S, Chun JL. Gut microbiota profiling in aged dogs after feeding pet food contained Hericium erinaceus. J Anim Sci Technol. 2022 Sep;64(5):937-949. Kaur J, Seshadri S, Golla KH, Sampara P. Efficacy and safety of standardized ashwagandha (Withania somnifera) root extract on reducing stress and anxiety in domestic dogs: A randomized controlled trial. J Vet Behav. 2022;51:8–15. Bharani KK, Devarasetti AK, Carey L, Khurana A, Kollipaka R, Hanuman DDV, Chetla VS, Banothu AK. Effects of ashwagandha (Withania somnifera) root extract on aging-related changes in healthy geriatric dogs: A randomized, double-blinded placebo-controlled study. Vet Med Sci. 2024 Sep;10(5):e1556 Sacoor C, Marugg JD, Lima NR, Empadinhas N, Montezinho L. Gut-brain axis impact on canine anxiety disorders: new challenges for behavioral veterinary medicine. Vet Med Int. 2024;2024:2856759. doi:10.1155/2024/2856759 Lee E, Carreras-Gallo N, Lopez L, Turner L, Lin A, Mendez TL, Went H, Tomusiak A, Verdin E, Corley M, Ndhlovu L, Smith R, Dwaraka VB. Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions. Aging (Albany NY). 2024;16(4):3088–3106. doi:10.18632/aging.205581 Bitto A, Ito TK, Pineda VV, LeTexier NJ, Huang HZ, Sutlief E, Tung H, Vizzini N, Chen B, Smith K, Meza D, Yajima M, Beyer RP, Kerr KF, Davis DJ, Gillespie CH, Snyder JM, Treuting PM, Kaeberlein M. Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice. eLife. 2016;5:e16351. doi:10.7554/eLife.16351 Urfer SR, Kaeberlein TL, Mailheau S, Bergman PJ, Creevy KE, Promislow DEL, Kaeberlein M. A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs. GeroScience. 2017;39(2):117–127. doi:10.1007/s11357-017-9972-z Kaeberlein M, Creevy KE, Promislow DEL. The Dog Aging Project: translational geroscience in companion animals. Mamm Genome. 2016;27(7–8):279–288. doi:10.1007/s00335-016-9638- Mulder IE, Schmidt B, Lewis M, Delday M, Stokes CR, Bailey M, Aminov RI, Gill BP, Pluske JR, Mayer CD, Kelly D. Restricting microbial exposure in early life negates the immune benefits associated with gut colonization in environments of high microbial diversity. PLoS One. 2011;6(12):e28279. doi:10.1371/journal.pone.0028279 Hemida M, Vuori KA, Moore R, Anturaniemi J, Hielm-Björkman A. Early life modifiable exposures and their association with owner-reported inflammatory bowel disease symptoms in adult dogs. Front Vet Sci. 2021;8:552350. doi:10.3389/fvets.2021.552350 McMahon JE, Graves JL, Tovar AP, Peloquin M, Greenwood K, Chen FL, Nelson M, McCandless EE, Halioua-Haubold CL, Juarez-Salinas D. Translational immune and metabolic markers of aging in dogs. Sci Rep. 2025;15:14460. doi:10.1038/s41598-025-51976-3 Urfer SR, Kaeberlein M. Desexing dogs: a review of the current literature. Animals (Basel). 2019;9(12):1086. doi:10.3390/ani9121086 Santos JDP, Cunha E, Nunes T, Tavares L, Oliveira M. Relation between periodontal disease and systemic diseases in dogs. Res Vet Sci. 2019;125:136–140. doi:10.1016/j.rvsc.2019.05.011 Selting KA, Ringold R, Husbands B, Pithua PO. Thymidine kinase type 1 and C-reactive protein concentrations in dogs with spontaneously occurring cancer. J Vet Intern Med. 2016;30(4):1159–1166. doi:10.1111/jvim.13954 Urfer SR, Kaeberlein M. Desexing dogs: a review of the current literature. Animals (Basel). 2019;9(12):1086. doi:10.3390/ani9121086 Clark JD, Rager DR, Crowell-Davis S, Evans DL. Housing and exercise of dogs: effects on behaviour, immune function and cortisol concentration. Lab Anim Sci. 1997;47(5):500–510 See omnystudio.com/listener for privacy information.

I'm so thrilled to have back on Dr. Chris Rhodes, Founder of Mimio. Dr. Chris Rhodes graduated from the University of California Davis with a PhD in Philosophy and Nutritional Biochemistry and is the founder of Mimio. Mimio is the world's first fasting mimetic designed from human biology to optimize metabolism and support longevity. In this episode, we discuss a new study in the process of being published that shows the benefits of Mimio in the real world. We discuss the findings and implications, what zombie cells are, combining Mimio with lifestyle, and much more!   Time Stamps:   (1:10) Episode 216 with Dr. Chris Rhodes (2:35) What Is Mimio? (5:37) Newest Research (11:43) Vital Ingredients In Mimio (21:10) Cellular State of Fasting (27:56) Brain Health (32:25) Zombie Cells (36:00) Case Studies (42:12) Combining Mimio and Lifestyle  (48:30) Where To Find Dr. Rhodes -------------------- Episode 216 with Dr. Rhodes Website: https://mimiohealth.com   Tik Tok: https://www.tiktok.com/@thatnutritiondr   Instagram: https://www.instagram.com/mimiohealth/ -------------------- Instagram: https://www.instagram.com/carolcovinofitness/ -------------------- My YouTube Channel: http://youtube.com/@carolcovinofitness -------------------- My Book:  FINDING PURPOSE IN THE PAUSE

We gain unprecedented access to the mini prison that sits beneath the country's largest court building, and get a tour of Cloverhill prison in an exclusive podcast. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Jon wants to know, how do the cells in the human body, in all their variety, differ at the genetic level? James Tytko took his query on... Like this podcast? Please help us by supporting the Naked Scientists

“This isn't just one gene edit—this is multiple edits, working in concert. It's a fundamentally different chassis.” In this episode of The Biotech Startups Podcast, Aaron Edwards, co-founder of KiraGen Bio, shares how a Harvard Business School class project ignited the launch of a pioneering biotech taking on solid tumors with a bold, unconventional CAR T-cell therapy. He unpacks the real-world challenges of building KiraGen—navigating fundraising, assembling a strong team, and leveraging mentorship, partnerships, and machine learning—while highlighting how focus, discipline, and authentic leadership can set a startup apart, even when it means breaking from industry norms.

The A.M. Update reports on a violent Cincinnati brawl where five suspects face charges after viral videos showed a mob brutally attacking a man and a woman, with Police Chief Teresa Theetge condemning the "cruel" act and noting only one of 100 bystanders called 911. Ohio gubernatorial candidate Vivek Ramaswamy spoke to victim Holly, a single mom left bloodied, highlighting official inaction. In Midtown Manhattan, a gunman with an assault rifle shot a police officer and a bystander at 345 Park Avenue before being neutralized, with no motive or identity yet confirmed. A federal judge blocks Trump's defunding of Planned Parenthood's Medicaid reimbursements, defying his tax legislation. Trump warns the UK on immigration during his Scotland visit, while the EU trade deal secures $600 billion in investments and lower tariffs. California Senator Alex Padilla pushes amnesty for long-term illegals, countered by JD Vance defending Trump's DOJ transparency on Jeffrey Epstein. Ghislaine Maxwell appeals her sex trafficking conviction, and Beto O'Rourke compares Trump to Hitler. A Reno casino shooting kills three, with the suspect arrested but motive unclear. A UK job ad for a Sharia court administrator sparks outrage, and RFK Jr. targets reform of the corrupt Vaccine Injury Compensation Program. Air analysis questions if random shootings in Manhattan and Reno could hint at Iran-linked sleeper cells activated post-border closure.   Cincinnati brawl, Manhattan shooting, Iran sleeper cells, Teresa Theetge, Vivek Ramaswamy, Planned Parenthood, Trump EU trade deal, UK immigration, Alex Padilla, JD Vance, Jeffrey Epstein, Ghislaine Maxwell, Beto O'Rourke, Reno shooting, Sharia court, RFK Jr., Vaccine Injury Compensation

My guest today is Melanie Moses, a Professor of Computer Science at the University of New Mexico, an External Faculty at the Santa Fe Institute, and Chair of the New Mexico AI Consortium. Melanie's work spans a wide range of disciplines all unified by her deep understanding of complexity theory.In our conversation, Melanie and I explore how scaling theory reveals surprising patterns across nature, technology, and society. We discuss what decentralized systems like ant colonies can teach us about building more robust AI, and what the immune system tells us about information networks. We also delve into the costs of building scalable infrastructure, and why we might need new approaches to governance that can scale with our global challenges. Finally, we explore whether there could ever be a universal scaling law and what young researchers should know about pursuing interdisciplinary paths. I hope you enjoy our discussion.You can follow me on X (@⁠ProfSchrepel⁠) and BlueSky (@⁠ProfSchrepel⁠).References:Melanie Moses' Biological Computation Lab https://moseslab.cs.unm.eduMetabolic Scaling From Individuals to Societies (PhD, 1993) https://www.unm.edu/~melaniem/DISSERTATION_MEM.pdfCities as Organisms: Allometric Scaling of Urban Road Networks (2008) https://www.jtlu.org/index.php/jtlu/article/view/29Biologically inspired design principles for Scalable, Robust, Adaptive, Decentralized search and automated response (RADAR) (2011) https://ieeexplore.ieee.org/document/5954663

Dr. Gary Null provided a classroom on the air titled "stem Cells", played clips on various topics and played the trailer for his upcoming documentary "Corruption of Science".

ReferencesInt J Mol Sci. 2020 Sep 22;21(18):6973.Cells. 2019 Mar; 8(3): 227.J Diabetes Complications. 2022 Oct 5;36(11):108333. Guerra, DJ. 2025. Lectures unpublishedCetera, P. 1969. "Liberation" Chicago Transit Authority lp.https://music.youtube.com/watch?v=4EPGCZ-eBSs&si=ICPGcKon4Ez4SAa-Beethoven, LV. 1802. Piano Concerto V. in E Flat Major. "The Emperor" OP 73.https://music.youtube.com/watch?v=WxMLHBZ4vOE&si=uBflUVY9uQB7vl5u

In this solo episode of the Bendy Bodies Podcast, Dr. Linda Bluestein tackles a series of complex listener questions originally submitted by clinicians after her guest appearance on The Curbsiders internal medicine podcast. From the flaws in the EDS diagnostic criteria to the misunderstood role of MTHFR gene (methylenetetrahydrofolate reductase), SVT (supraventricular tachycardia), celiac disease, and mast cell medications, she offers guidance, clarity, and practical advice. She also digs into how to find a provider who actually understands dysautonomia and shares personal hacks that empower patients to ask smarter questions during appointments. This episode is a toolkit for patients and providers alike, packed with real-world insights you won't want to miss. Takeaways: Why Beighton scoring alone doesn't cut it for diagnosing EDS The truth about MTHFR variants and their link to EDS The overlap between SVT, POTS, and when to worry What to ask your doctor if you're not sure they "get" dysautonomia A breakdown of meds like LDN, ketotifen, and cromolyn—and who they help most References: The Curbsiders Podcast EP 480 - Hypermobility with Dr. Linda Bluestein: https://thecurbsiders.com/curbsiders-podcast/480-hypermobility-with-dr-linda-bluestein https://pubmed.ncbi.nlm.nih.gov/38523329/?utm_source=chatgpt.com hEDS Diagnostic Criteria Checklist Red Flags Guide (credit: Clair A. Francomano, MD): https://www.bendybodiespodcast.com/p/redflags/ Hope for Hypermobility Article: https://www.nursingcenter.com/cearticle?an=00587875-202304000-00001&Journal_ID=3402523&Issue_ID=6649307 Substack: https://open.substack.com/pub/hypermobilitymd/p/navigating-treatment-for-hedshsd Find the episode transcript here Bendy Bodies EP 133: How Internists Think About Complex Illness with Dr. Matthew Watto: https://www.bendybodiespodcast.com/how-internists-think-about-complex-illness-with-dr-matthew-watto-ben-133/ Bendy Bodies EP 139: Hidden Histamine Threats with Dr. Theoharis Theoharides: https://www.bendybodiespodcast.com/hidden-histamine-threats-with-dr-theoharis-theoharides-ep-139/ Cromolyn Douche Article: https://pubmed.ncbi.nlm.nih.gov/30964355/ https://www.bendybodiespodcast.com/videos/connective-tissue-disorders-and-lipedema-with-karen-herbst-md/ LDN episode: https://www.bendybodiespodcast.com/lower-your-eds-pain-office-hours-ep-138/ LDN resource: https://www.bendybodiespodcast.com/p/low-dose-naltrexone-ldn-for-chronic-pain-eds/ Want more Dr. Linda Bluestein, MD? Website:  ⁠⁠https://www.hypermobilitymd.com/⁠⁠. YouTube: ⁠⁠⁠youtube.com/@bendybodiespodcast⁠⁠⁠  Instagram: ⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠  Facebook: ⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠  X: ⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠  LinkedIn: ⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠  Newsletter: ⁠⁠⁠https://hypermobilitymd.substack.com/⁠⁠⁠ Shop my Amazon store ⁠⁠⁠https://www.amazon.com/shop/hypermobilitymd⁠⁠⁠ Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority! Use this affiliate link for Algonot to get an extra 5% off your entire order: ⁠⁠https://algonot.com/coupon/bendbod/⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

In this solo episode of the Bendy Bodies Podcast, Dr. Linda Bluestein tackles a series of complex listener questions originally submitted by clinicians after her guest appearance on The Curbsiders internal medicine podcast. From the flaws in the EDS diagnostic criteria to the misunderstood role of MTHFR gene (methylenetetrahydrofolate reductase), SVT (supraventricular tachycardia), celiac disease, and mast cell medications, she offers guidance, clarity, and practical advice. She also digs into how to find a provider who actually understands dysautonomia and shares personal hacks that empower patients to ask smarter questions during appointments. This episode is a toolkit for patients and providers alike, packed with real-world insights you won't want to miss. Takeaways: Why Beighton scoring alone doesn't cut it for diagnosing EDS The truth about MTHFR variants and their link to EDS The overlap between SVT, POTS, and when to worry What to ask your doctor if you're not sure they "get" dysautonomia A breakdown of meds like LDN, ketotifen, and cromolyn—and who they help most References: The Curbsiders Podcast EP 480 - Hypermobility with Dr. Linda Bluestein: https://thecurbsiders.com/curbsiders-podcast/480-hypermobility-with-dr-linda-bluestein https://pubmed.ncbi.nlm.nih.gov/38523329/?utm_source=chatgpt.com hEDS Diagnostic Criteria Checklist Red Flags Guide (credit: Clair A. Francomano, MD): https://www.bendybodiespodcast.com/p/redflags/ Hope for Hypermobility Article: https://www.nursingcenter.com/cearticle?an=00587875-202304000-00001&Journal_ID=3402523&Issue_ID=6649307 Substack: https://open.substack.com/pub/hypermobilitymd/p/navigating-treatment-for-hedshsd Find the episode transcript here Bendy Bodies EP 133: How Internists Think About Complex Illness with Dr. Matthew Watto: https://www.bendybodiespodcast.com/how-internists-think-about-complex-illness-with-dr-matthew-watto-ben-133/ Bendy Bodies EP 139: Hidden Histamine Threats with Dr. Theoharis Theoharides: https://www.bendybodiespodcast.com/hidden-histamine-threats-with-dr-theoharis-theoharides-ep-139/ Cromolyn Douche Article: https://pubmed.ncbi.nlm.nih.gov/30964355/ https://www.bendybodiespodcast.com/videos/connective-tissue-disorders-and-lipedema-with-karen-herbst-md/ LDN episode: https://www.bendybodiespodcast.com/lower-your-eds-pain-office-hours-ep-138/ LDN resource: https://www.bendybodiespodcast.com/p/low-dose-naltrexone-ldn-for-chronic-pain-eds/ Want more Dr. Linda Bluestein, MD? Website:  ⁠⁠https://www.hypermobilitymd.com/⁠⁠. YouTube: ⁠⁠⁠youtube.com/@bendybodiespodcast⁠⁠⁠  Instagram: ⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠  Facebook: ⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠  X: ⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠  LinkedIn: ⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠  Newsletter: ⁠⁠⁠https://hypermobilitymd.substack.com/⁠⁠⁠ Shop my Amazon store ⁠⁠⁠https://www.amazon.com/shop/hypermobilitymd⁠⁠⁠ Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority! Use this affiliate link for Algonot to get an extra 5% off your entire order: ⁠⁠https://algonot.com/coupon/bendbod/⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

Roger Seheult, MD of MedCram examines a new study that confirms near infrared light can affect mitochondria in areas of the body that are not directly exposed. See all Dr. Seheult's videos at: https://www.medcram.com/ (This video was recorded on July 14th, 2025) Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT:  Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-c... Video Produced by Kyle Allred FOLLOW US ON SOCIAL MEDIA: https://www.facebook.com/MedCram https://twitter.com/MedCramVideos https://www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide a comprehensive look at the growing challenge of EOCRC. Hosts: - Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center - Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian - Dr. Phil Bauer, Graduating Colorectal Surgical Oncology Fellow at Memorial Sloan Kettering Cancer Center  - Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer Center - Dr. Andrea Cercek - Gastrointestinal Medical Oncologist at Memorial Sloan Kettering Cancer Center - Dr. Y. Nancy You, MD MHSc - Professor, Department of Colon and Rectal Surgery at MD Anderson Cancer Center Learning objectives:  - Describe trends in incidence of colorectal cancer, with emphasis on the rise of EOCRC. - Identify age groups and demographics most affected by EOCRC. - Summarize USPSTF recommendations for colorectal cancer screening. - Distinguish between screening methods (e.g., colonoscopy, FIT-DNA) and their sensitivity. - Understand treatment approaches for colon and rectal cancer (CRC) - Understand the role of mismatch repair (MMR) status in guiding treatment. - Outline the importance of genetic counseling and testing in young patients. - Discuss racial, ethnic, and socioeconomic disparities in CRC incidence and outcomes. - Describe the impact of cancer treatment on fertility and sexual health. -  Review fertility preservation options. - Identify the value of integrated care teams for young CRC patients. References: 1.         Siegel, R. L. et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013. JNCI J. Natl. Cancer Inst. 109, djw322 (2017). https://pubmed.ncbi.nlm.nih.gov/28376186/ 2.         Abboud, Y. et al. Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis. Cancers 17, 1500 (2025). https://pubmed.ncbi.nlm.nih.gov/40361427/ 3.         Phang, R. et al. Is the Incidence of Early-Onset Adenocarcinomas in Aotearoa New Zealand Increasing? Asia Pac. J. Clin. Oncol.https://pubmed.ncbi.nlm.nih.gov/40384533/ 4.         Vitaloni, M. et al. Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries. BMC Gastroenterol. 25, 378 (2025). https://pubmed.ncbi.nlm.nih.gov/40375142/ 5.         Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. (2019) doi:10.1136/gutjnl-2019-319511. https://pubmed.ncbi.nlm.nih.gov/31488504/ 6.         Cercek, A. et al. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. J. Natl. Cancer Inst. 113, 1683–1692 (2021). https://pubmed.ncbi.nlm.nih.gov/34405229/ 7.         Zheng, X. et al. Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer. JNCI J. Natl. Cancer Inst. 113, 543–552 (2021). https://pubmed.ncbi.nlm.nih.gov/33136160/ 8.         Standl, E. & Schnell, O. Increased Risk of Cancer—An Integral Component of the Cardio–Renal–Metabolic Disease Cluster and Its Management. Cells 14, 564 (2025). https://pubmed.ncbi.nlm.nih.gov/40277890/ 9.         Muller, C., Ihionkhan, E., Stoffel, E. M. & Kupfer, S. S. Disparities in Early-Onset Colorectal Cancer. Cells 10, 1018 (2021). https://pubmed.ncbi.nlm.nih.gov/33925893/ 10.       US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 325, 1965–1977 (2021). https://pubmed.ncbi.nlm.nih.gov/34003218/ 11.       Fwelo, P. et al. Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors. Cancer Med. 14, e70612 (2025). https://pubmed.ncbi.nlm.nih.gov/40040375/ 12.       Lansdorp-Vogelaar, I. et al. Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates. Cancer Epidemiol. Biomarkers Prev. 21, 728–736 (2012). https://pubmed.ncbi.nlm.nih.gov/22514249/ 13.       Ko, T. M. et al. Low neighborhood socioeconomic status is associated with poor outcomes in young adults with colorectal cancer. Surgery 176, 626–632 (2024). https://pubmed.ncbi.nlm.nih.gov/38972769/ 14.       Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA. Cancer J. Clin. 73, 233–254 (2023). https://pubmed.ncbi.nlm.nih.gov/36856579/ 15.       Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A. & May, F. P. Optimal Strategies for Colorectal Cancer Screening. Curr. Treat. Options Oncol. 23, 474–493 (2022). https://pubmed.ncbi.nlm.nih.gov/35316477/ 16.       Zauber, A. G. The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference? Dig. Dis. Sci. 60, 681–691 (2015). https://pubmed.ncbi.nlm.nih.gov/25740556/ 17.       Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544–573 (2010). https://pubmed.ncbi.nlm.nih.gov/19998273/ 18.       Cercek, A. et al. Nonoperative Management of Mismatch Repair–Deficient Tumors. New England Journal of Medicine 392, 2297–2308 (2025). https://pubmed.ncbi.nlm.nih.gov/40293177/ 19.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations. Cancers 17, 1325 (2025). https://pubmed.ncbi.nlm.nih.gov/40282501/ 20.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer. Cancers 17, 1093 (2025). https://pubmed.ncbi.nlm.nih.gov/40227607/ 21.       Benson, A. B. et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. JNCCN 19, 329–359 (2021). https://pubmed.ncbi.nlm.nih.gov/33724754/ 22.       Christenson, E. S. et al. Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/40388545/ 23.       Dasari, A. et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. The Lancet 402, 41–53 (2023). https://pubmed.ncbi.nlm.nih.gov/37331369/ 24.       Strickler, J. H. et al. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Lancet Oncol. 24, 496–508 (2023). https://pubmed.ncbi.nlm.nih.gov/37142372/ 25.       Sauer, R. et al. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N. Engl. J. Med. 351, 1731–1740 (2004). https://pubmed.ncbi.nlm.nih.gov/15496622/ 26.       Cercek, A. et al. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol. 4, e180071 (2018). https://pubmed.ncbi.nlm.nih.gov/29566109/ 27.       Garcia-Aguilar, J. et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J. Clin. Oncol. 40, 2546–2556 (2022). https://pubmed.ncbi.nlm.nih.gov/35483010/ 28.       Schrag, D. et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N. Engl. J. Med. 389, 322–334 (2023). https://pubmed.ncbi.nlm.nih.gov/37272534/ 29.       Kunkler, I. H., Williams, L. J., Jack, W. J. L., Cameron, D. A. & Dixon, J. M. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N. Engl. J. Med. 388, 585–594 (2023). https://pubmed.ncbi.nlm.nih.gov/36791159/ 30.       Jacobsen, R. L., Macpherson, C. F., Pflugeisen, B. M. & Johnson, R. H. Care Experience, by Site of Care, for Adolescents and Young Adults With Cancer. JCO Oncol. Pract. (2021) doi:10.1200/OP.20.00840. https://pubmed.ncbi.nlm.nih.gov/33566700/ 31.       Ruddy, K. J. et al. Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer. J. Clin. Oncol. (2014) doi:10.1200/JCO.2013.52.8877. https://pubmed.ncbi.nlm.nih.gov/24567428/ 32.       Su, H. I. et al. Fertility Preservation in People With Cancer: ASCO Guideline Update. J. Clin. Oncol. 43, 1488–1515 (2025). https://pubmed.ncbi.nlm.nih.gov/40106739/ 33.       Smith, K. L., Gracia, C., Sokalska, A. & Moore, H. Advances in Fertility Preservation for Young Women With Cancer. Am. Soc. Clin. Oncol. Educ. Book 27–37 (2018) doi:10.1200/EDBK_208301. https://pubmed.ncbi.nlm.nih.gov/30231357/ 34.       Blumenfeld, Z. How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries. The Oncologist 12, 1044–1054 (2007). 35.       Bhagavath, B. The current and future state of surgery in reproductive endocrinology. Curr. Opin. Obstet. Gynecol. 34, 164 (2022). 36.       Ribeiro, R. et al. Uterine transposition: technique and a case report. Fertil. Steril. 108, 320-324.e1 (2017). 37.       Yazdani, A., Sweterlitsch, K. M., Kim, H., Flyckt, R. L. & Christianson, M. S. Surgical Innovations to Protect Fertility from Oncologic Pelvic Radiation Therapy: Ovarian Transposition and Uterine Fixation. J. Clin. Med. 13, 5577 (2024). 38.       Holowatyj, A. N., Eng, C. & Lewis, M. A. Incorporating Reproductive Health in the Clinical Management of Early-Onset Colorectal Cancer. JCO Oncol. Pract. 18, 169–172 (2022). ***Behind the Knife Colorectal Surgery Oral Board Audio Review: https://app.behindtheknife.org/course-details/colorectal-surgery-oral-board-audio-review Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Renowned anti-aging expert Dr. Bill Andrews rejoins the show for a powerful conversation about the future of aging—and how extending healthspan could radically reshape society. We ask the tough questions:Is it ethical to slow or reverse aging if it means more people live longer? Or is it our responsibility to help those who are suffering in a weakened, isolated, and often overlooked state? Dr. Andrews argues that extending vitality isn't just possible—it's the humane and logical thing to do. We explore what a future might look like where people live longer but stay healthy, active, and mentally sharp. Could extended life bring a new wave of explorers, innovators, and contributors instead of burdens on the system? Plus, we're excited to announce the launch of Telo-Vital—the most promising telomere-lengthening supplement to date, now available at a price accessible to everyday people. This product is the result of years of cutting-edge research and could represent a major breakthrough in real, affordable anti-aging science.You can buy telo-vital for only $39 at https://grow.thegoodinside.com/special-offer-telo-vital-892649-lp

Send us a textThis week on The Less Stressed Life, Morley Robbins returns to unpack the misunderstood role of copper in energy production, iron regulation, and chronic fatigue. We explore how stress, poor soil quality, and modern health trends have created a widespread mineral imbalance—and why copper might be the missing link for those struggling with burnout, low energy, or hormonal chaos.If you've ever been told you're “low iron” or feel like your energy tank is always on empty, this conversation might just reframe everything you thought you knew about your metabolism.KEY TAKEAWAYS:Why you can't make energy without copperHow stress and glyphosate deplete bioavailable mineralsWhy most iron labs miss the real issueThe difference between copper supplements and true bioavailable copperHow to start supporting your mineral balanceABOUT GUEST:Morley Robbins is the creator of the Root Cause Protocol and founder of the Magnesium Advocacy Group. Known as the “Magnesium Man,” Morley left a decades-long career in hospital administration after a personal healing experience led him to question everything he thought he knew about health. Since then, he's become a passionate educator on mineral balance, performing thousands of consults and digging deep into the roles of magnesium, copper, and iron in chronic illness. Through his research and coaching, Morley helps people get to the root cause of fatigue, inflammation, and hormonal imbalances—one mineral at a time.WHERE TO FIND:Website: https://therootcauseprotocol.com/Instagram: https://www.instagram.com/therootcauseprotocol/WHERE TO FIND CHRISTA:Website: https://www.christabiegler.com/Instagram: @anti.inflammatory.nutritionistPodcast Instagram: @lessstressedlifeYouTube: https://www.youtube.com/@lessstressedlifeNUTRITION PHILOSOPHY OF LESS STRESSED LIFE:

BUFFALO, NY - July 16, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on July 9, 2025, titled “A novel anti-human CD25 mAb with preferential reactivity to activated T regulatory cells depletes them from the tumor microenvironment.” In this study, researchers from the National Institute of Allergy and Infectious Diseases, led by first author Maja Buszko and corresponding author Ethan M. Shevach, discovered a new monoclonal antibody that selectively targets a subset of immune cells called regulatory T cells (Tregs). These cells, while normally important for preventing autoimmunity, also can block the body's ability to fight cancer by suppressing anti-tumor immune responses. This discovery could lead to novel cancer therapies that strengthen the immune system's capacity to attack tumors. The researchers identified an anti-CD25 monoclonal antibody with several atypical properties and named it 2B010. To evaluate its effects, they used humanized mice, laboratory mice that are engineered to carry human immune cells, to closely mimic how human immune systems respond to cancer. The treatment of these mouse models with 2B010 significantly decreased the number of Tregs in tumors and boosted the activity of CD8+ T cells, which are essential for killing cancer cells. Importantly, 2B010 worked without disrupting other key immune functions. Unlike traditional Anti-CD25 antibodies, it did not interfere with interleukin-2 (IL-2) signaling, which is essential for the growth and activity of effector T cells that fight cancer. “2B010 also had no effect on IL-2 induced STAT5 phosphorylation or CD4+ T cell proliferation in vitro while both were blocked by Clone D1 further supporting the view that 2B010 does not recognize the IL-2 binding site.” This finding is especially significant because high levels of Tregs in tumors are associated with poor outcomes in many cancers. By specifically removing these cells, 2B010 may help overcome one of the main barriers to current immunotherapy approaches. Its ability to preserve IL-2 signaling could also make it safer and more effective when used alone or in combination with existing therapies such as immune checkpoint inhibitors. While the 2B010 antibody showed strong effects in reducing Tregs and boosting immune cell activity, the study did not observe changes in tumor size in these models. Researchers suggest this may be due to limitations in the preclinical systems used, such as the lack of tumor-specific T cells in humanized mice. Nevertheless, these findings demonstrate that 2B010 has a unique mechanism of action that could complement other cancer immunotherapies in future clinical trials. In conclusion, the development of 2B010 is a promising step toward selectively disrupting the immune suppressive environment in tumors. As researchers continue to refine and test this antibody, it could become a powerful tool for enhancing the effectiveness of cancer treatments and improving outcomes for patients. DOI - https://doi.org/10.18632/oncotarget.28752 Correspondence to - Ethan M. Shevach - eshevach@Niaid.NIH.gov Video short - https://www.youtube.com/watch?v=2NJcGsI7WXA Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28752 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, Treg, CD25, TME, mAb, GVHD To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Hey Heal Squad! Today, Maria sits down with physician and researcher Dr. William Makis to explore the deeper patterns emerging in our health! They discuss topics like why so many people are experiencing unexplained fatigue, chronic inflammation, and even earlier cancer diagnoses (what?!). Dr. Makis shares why our immune systems are more overwhelmed than ever, and how environmental stressors are taxing the body's natural ability to heal. He breaks down what's changed in the past few years, what warning signs to look for, and how to support your body so it stays resilient and strong. You'll learn how to recognize the early red flags of immune dysfunction, what lifestyle choices could be feeding inflammation, and what it really takes to create an internal environment where your body can protect and restore itself. This is your sign to take care of your wellness from the inside out! Tune in!!  HEALERS & HEAL-LINERS:  Chronic inflammation is a warning sign. Many cancers and autoimmune conditions begin with low-level inflammation that goes unchecked, tuning into early symptoms like fatigue, brain fog, or skin changes can help you take action before bigger issues arise. Your immune system is your greatest defense. When supported properly (through sleep, light, nutrition, and detox), your immune system can identify and destroy abnormal cells before they become disease. The “new normal” isn't normal. More people are experiencing mystery symptoms, early cancer, and immune dysfunction, Dr. Makis will help you understand why it's happening and how to reverse course. -- HEAL SQUAD SOCIALS IG: https://www.instagram.com/healsquad/ TikTok: https://www.tiktok.com/@healsquadxmaria HEAL SQUAD RESOURCES: Heal Squad Website:https://www.healsquad.com/ Heal Squad x Patreon: https://www.patreon.com/HealSquad/membership Maria Menounos Website: https://www.mariamenounos.com My Curated Macy's Page: Shop My Macy's Storefront Prenuvo: Prenuvo.com/MARIA for $300 off Delete Me: https://bit.ly/43rkHwi   code: SQUAD EMR-Tek Red Light: https://emr-tek.com/discount/Maria30 for 30% off Airbnb: https://www.airbnb.com/  Join In-Person Heal Retreat Waitlist! https://mariamenounos.myflodesk.com/heal-retreat-waitlist GUEST RESOURCES: Instagram: https://www.instagram.com/wmakismd/?hl=en  Website: https://www.twc.health/  For anyone wanting more information on how Ivermectin, fenbendazole, and mebendazole works, or need dosing protocols, connect with Dr. Makis makisw79@yahoo.com Or visit his Substack makismd.substack.com ABOUT MARIA MENOUNOS: Emmy Award-winning journalist, TV personality, actress, 2x NYT best-selling author, former pro-wrestler and brain tumor survivor, Maria Menounos' passion is to see others heal and to get better in all areas of life. ABOUT HEAL SQUAD x MARIA MENOUNOS: A daily digital talk-show that brings you the world's leading healers, experts, and celebrities to share groundbreaking secrets and tips to getting better in all areas of life. DISCLAIMER: This Podcast and all related content (published or distributed by or on behalf of Maria Menounos or http://Mariamenounos.com and http://healsquad.com) is for informational purposes only and may include information that is general in nature and that is not specific to you. Any information or opinions provided by guest experts or hosts featured within website or on Company's Podcast are their own; not those of Maria Menounos or the Company. Accordingly, Maria Menounos and the Company cannot be responsible for any results or consequences or actions you may take based on such information or opinions. This podcast is presented for exploratory purposes only. Published content is not intended to be used for preventing, diagnosing, or treating a specific illness. If you have, or suspect you may have, a health-care emergency, please contact a qualified health care professional for treatment.

How Long will Humans Live? Immortal Reproductive Cells, Future of Anti-Aging w/ Dr. Bill Andrews - SarahWestall.com

326. Australia, Testosterone, Mast Cells and More In this episode, I sit down with Dr. Ceri Cashell for a wide-ranging conversation that spans continents and dives deep into women's health—from hormones to mast cells to medical mindset. Dr. Cashell and I talk about what we're seeing in clinical practice and what women around the world are still fighting for: access, advocacy, and actual answers. We unpack the critical role of testosterone in women's health (yes, women have and need testosterone), and explore how cultural perceptions—especially around sexuality—still shape what treatments women are offered or denied. We also talk about mast cell activation syndrome and how it might explain so many symptoms that often get brushed off or misdiagnosed in women. We get into why vaginal DHEA is so underutilized, how lifestyle changes make a real impact, and why curiosity in medicine is a superpower. There's also a deep dive into the hormone–mental health connection and why so many women are struggling in silence because of outdated medical thinking. This episode is a reminder: women's health is not niche, and we deserve better. Takeaways: Testosterone isn't optional—it's vital for women's health, especially during midlife. Cultural norms around sexuality still impact the care women receive. Mast cell activation syndrome might be the missing puzzle piece for many women with unexplained symptoms. We need more advocacy to break through the outdated thinking that limits women's treatment options. Lifestyle changes matter—more than most doctors admit. Staying curious as a clinician can change the game for patients. Vaginal DHEA is safe, effective, and overlooked far too often. Hormones are deeply connected to mental health—this isn't just about libido. Access to hormone therapy is often blocked by stigma, not science. Education and awareness are the keys to transforming women's healthcare. Australian petition to put Androfeme on PBS https://www.instagram.com/drcericashell/ https://www.healthyhormones.au/ https://drcericashell.com/ Want more honest, empowering conversations like this one?⁠⁠⁠Preorder my Next Book⁠⁠⁠ share this episode, and leave a review to help others find this important work. Let's stop leaving women out of the conversation—especially when it comes to sex, health, and healing. Listen to my Tedx Talk: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Why we need adult sex ed⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠Take my Adult Sex Ed Master Class:⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠My Website⁠⁠⁠⁠⁠⁠⁠⁠⁠ Interested in my sexual health and hormone clinic? ⁠⁠⁠⁠⁠⁠⁠⁠⁠Waitlist is open⁠⁠⁠⁠⁠⁠⁠⁠ Explore and expand pleasure with resources, advice, and the most exciting pleasure products with Good Vibes, and save 10% with coupon code NOTBROKEN10 at ⁠goodvibes.com/menopause⁠ Thanks to our sponsor ⁠⁠⁠⁠⁠⁠⁠⁠⁠Midi Women's Health⁠⁠⁠⁠⁠⁠⁠⁠⁠. Designed by midlife experts, delivered by experienced clinicians, covered by insurance.Midi is the first virtual care clinic made exclusively for women 40+. Evidence-based treatments. Personalized midlife care.⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.joinmidi.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

ReferencesMol Cancer Ther. 2018 Jan; 17(1): 50–59 J Neuroinflammation. 2019; 16: 236. Cell Host Microbe. 2016 Feb 10; 19(2): 181–193Nat Rev Microbiol. 2009 Feb; 7(2): 99–109.Cells.2020 Feb 5;9(2).Biochimica et Biophysica Acta (BBA) - Biomembranes. 2016.Volume 1858, Issue 11, November Pages 2681-2688Nat Immunol. 2024 Apr 8;25(5):778–789. Dylan, B. 1975. "Tangled up in Blue"https://music.youtube.com/playlist?list=OLAK5uy_nHWCTvQI-G4uNRNvC0AjQr9hVXG54TeSU&si=xOVhlpdBm_ygXirlMcQuinn 1971. "Pale Blue" Byrdmaniax l phttps://youtu.be/Mh3J7GqrdzY?si=UtahiK75LoZhQLe7Baker, G. 1967. "Blue Condition" Cream Disraeli Gears lp.https://youtu.be/bOAkjNX1FDI?si=3q_FcsfvWTH95RyK

Psychologist Dr. Carole Lieberman joins the program to unpack the rising wave of extreme ideas and behaviors spreading across the United States and the world. From political rhetoric to violent unrest, we explore how war, propaganda, and polarized thinking are fueling emotional instability and social division. We also dive into a spirited debate on the Middle East, examining the extreme actions and narratives emerging from all sides of the conflict.Dr. Lieberman offers insight into the psychological toll of chaos—and how individuals can stay grounded in turbulent times in her weekly podcast. You can learn more at https://terroristtherapist.com, https://www.drcarole.com or on X @DrCaroleMD

Commissioner of US Customs and Border Protection, Rodney Scott, says the US should be worried about the amount of terrorist sleeper cells that have been allowed into the country due to border policies. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Aaron and Dexter Van Zile in a conversation about the spread of radical Islam in the United States. Dexter is the managing editor of Focus on Western Islam at the Middle East Forum.

A young man was diagnosed with leukemia, Lo Aleinu. Baruch Hashem, he is now responding well to treatment. One day, his rabbi noticed that he was praying the Amidah with deep concentration and asked what inspired such intense kavanah. The young man replied that his doctor had recently explained to him how cancer begins. He said, "If even one single cell in the body mutates and begins to do the wrong thing, and then multiplies, it can become cancer." The young man continued, "I learned that the human body has more than 37 trillion cells, and all it takes is for just one to go off track." This struck him deeply. He began to think about the 37 trillion cells in his body that were doing exactly what they were supposed to, every moment. He realized how much he owed Hashem and felt an urge to say thank you for each and every one. So he did the math: if he wanted to say thank you for each cell, and it took just two seconds per "thank you" with real kavanah, and he did it nonstop 24 hours a day, how long would it take? His calculation came out to nearly 2.5 million years . That's what inspired him to say the Amidah with more heart and awareness—because he realized how Hashem is sustaining him with countless daily miracles. Each microscopic cell in our body is like a miniature city, with roads, factories, and workers. Cells contain tiny "machines" that produce energy, repair damage, send signals, and make proteins. Red blood cells deliver oxygen to every part of the body, completing a round trip in just one minute. There are about 25 trillion red blood cells alone. The cells send chemical messages to each other that instruct them to grow, heal, or repair. The brain, meanwhile, has 86 billion neurons firing electrical signals at lightning speed. Inside each cell lies a copy of a person's DNA, a blueprint so compact that if stretched out, it would measure six feet long—but it's packed inside something invisible to the eye. Even as we sleep, these trillions of cells continue to work— repairing damage, rebuilding muscles, cleaning waste and growing new tissues. —without pause. We could never fully thank Hashem for all He does for us. But we do get an opportunity each time we say "Asher Yatzar" to acknowledge and appreciate the intricate wonders of our body. We conclude that berachah by saying: רופא כל בשר ומפליא לעשות — "Healer of all flesh and Performer of wonders." Those wonders include our immune system, our blood cells, our nerve cells, our brain cells, our skin, our organs—and everything else that keeps functioning perfectly without our even noticing. Rebbetzin Silverstein recently shared a remarkable story. A mother had a child who could not control his bladder or bowels, and because of it, he was unable to attend school. Doctors could not help, and the parents were devastated. Then, the mother learned about the segulah of saying Asher Yatzar slowly, with kavanah, standing still, and reading it from a printed card. She began doing this every single time. Just a few weeks later, her son was miraculously healed. The doctors were stunned. The mother also said that recently, while shopping, she needed to use the restroom but couldn't find her Asher Yatzar card. She felt torn—not wanting to lose her kavanah. Just then, as if sent from Heaven, a man walked in and hung up an Asher Yatzar card on the wall. She was overwhelmed with gratitude. Hashem had answered her need at the perfect moment. We could thank Hashem every minute of our lives and still not come close to what He deserves. But the thanks we do give—if offered with heart and focus—can be incredibly powerful. Let us treasure every breath, every heartbeat, and every functioning cell—and use our moments of awareness to thank the One who never stops giving. If anyone would like to read a short write-up on specific kavanot to have during Asher Yatzar, click on the link at the bottom of today's transcript. To receive the email, you can sign up at livingemunah.com or send a request to livingemunah123@gmail.com . https://www.dropbox.com/scl/fi/pyh95lif97je64ncdavei/Asher-yatzar-booklet-inside.pdf?rlkey=ypna9iig1pfqhrmif6bzpktqt&st=1ti1iv74&dl=0

This episode was recorded at the 2025 Florida Ruminant Nutrition Symposium.  Dr. Baumgard begins with an overview of his presentation, “Importance of gut health to drive animal performance and health.” He notes the metabolic and inflammatory fingerprint of all stressors is essentially the same, indicating they likely all emanate from the gut. Overall, we're gaining a better understanding of how typical on-farm stressors negatively influence gut barrier function. He thinks the most likely mechanism of leaky gut is the immune cell known as a mast cell. When an animal or human is stressed, the enteric nervous system releases corticotropin-releasing factor, which binds to the mast cell, the mast cell degranulates, and the former contents of the mast cell (TNF-alpha, proteases, histamine, etc.) causes the gut to become leaky. (4:20)Once the GI tract barrier becomes compromised, antigens like lipopolysaccharide (LPS) can infiltrate, stimulating the immune system. Immune activation causes loss of appetite much like any other infection. The gut heals fairly quickly upon removal of the stressor(s), and the gut can also acclimate to stress such that the early stages of a stress event are more severe than later stages. Strategies to combat leaky gut remain scarce, and there is no silver bullet. There are a variety of dietary strategies to target the gut permeability issue itself. Another approach would be to bind pathogens or curb their proliferation at the membrane of the small intestine. (7:06)Dr. Neiehues asks if an antihistamine would work on gut mast cells the way it does in other body systems. Dr. Baumgard isn't sure that's ever been looked at, although there have been some studies in pigs using a product targeted to prevent mast cell degranulation. Dr. Nelson wonders if we should interfere in some of these processes because they're obviously there for a reason. Panelists discuss stress events related to parturition and transition, particularly for first-calf heifers. Dr. Baumgard notes that stacking stressors on top of one another compromises an animal's ability to tolerate stress. (9:28)We know stress can cause ulcers in humans and horses - what about ruminants? Dr. Baumgard thinks it is likely that it's happening, but we aren't looking for it. Few animals who die on-farm do receive a thorough postmortem exam. It could also be that these types of insults to the gut are not visible to the naked eye. (19:11)Dr. Nelson asks what makes some cows, despite all the challenges, able to be up and milking 150 pounds a day in no time after calving. What makes them unique? Dr. Baumgard lists some possibilities, including lower pathogenic inflammation than other cows, less tissue trauma damage to the uterus during calving, and lower sensitivity to immune activation. The panel disagrees with the notion that high-producing cows are stressed. (23:16)Dr. Niehues and Dr. Baumgard trade stories of experiments where cows maintained production even with high stress and inflammatory markers. The panel goes on to discuss subclinical infections and their impact on transition cows. Dr. Nelson notes there are retrospective datasets where cows who had metritis showed decreased feed intake even before calving. Dr. Baumgard feels that the decrease in intake has been incorrectly assumed to be the cause of the metritis. He says the decrease in intake is often around two weeks before calving and he doesn't think it's a coincidence that at the same time, the mammary gland is initiating lactogenesis. He hypothesizes the mammary gland is causing an immune response, resulting in a decrease in intake. Dr. Nelson wonders if measuring somatic cell counts of colostrum would show any differences in mammary gland inflammation during this prepartum period. (29:18)Panelists share their take-home thoughts. (42:02)Please subscribe and share with your industry friends to invite more people to join us at the Real Science Exchange virtual pub table.  If you want one of our Real Science Exchange t-shirts, screenshot your rating, review, or subscription, and email a picture to anh.marketing@balchem.com. Include your size and mailing address, and we'll mail you a shirt. 

Dr. Michelle Starz-Gaiano is Professor and Chair of Biological Sciences at the University of Maryland Baltimore County (UMBC). Michelle's research uses fruit flies to examine how cells in the body go to the right place at the right time. Understanding why and how cells use their genetic information to move through the body is critical because if this movement doesn't happen correctly, it could, for example, impact embryo development or affect how immune cells mobilize after an injury. Conversely, preventing cancer cells from moving could keep cancer from spreading to other parts of the body. Michelle often spends her free time cooking and baking. Her kitchen looks a little like a lab, and she enjoys experimenting with making different foods. Michelle and her family also like to spend time together, travel, and listen to music. She received her bachelor's degree in biology from the Massachusetts Institute of Technology and her PhD in Developmental Genetics from New York University. Afterwards, Michelle completed a postdoctoral fellowship at Johns Hopkins School of Medicine. She joined UMBC in 2008 and has received the Donald Creighton Outstanding Faculty Member Award from the UMBC Graduate Student Association for her excellent mentorship. In our interview, she shares more about her life and science.

Today's topics include potential Iranian response to the destruction of the nuclear sites and uranium enrichment facilities, the possibility of sleeper cell activation on U.S. soil, and all the cool stuff that got cut out of the Big Beautiful Bill. Patreon:  patreon.com/TGFP24 FB: https://www.facebook.com/profile.php?id=61557361379237 Instagram: https://www.instagram.com/twoguysandafencepost/ Tik Tok: https://www.tiktok.com/@two.guys.and.a.fe Youtube: https://www.youtube.com/@youmeafp Podbean: https://theguysn.podbean.com/ Apple Pod: https://podcasts.apple.com/us/podcast/two-guys-and-a-fence-post/id1746635990 Spotify: https://open.spotify.com/show/0J75SgIUHqkCwuFL6Vxi5D?si=tExV44bwTIqlyaRh9PNwXQ Berserker Tactics: https://berserkertactics.com/ FB:https://www.facebook.com/berserkertactics?mibextid=LQQJ4d IG:https://www.instagram.com/berserkertactics2?igsh=dDloZ3puMGJ4cmU2

Joint aches. Softer muscles. Saggy skin. Brain fog.  Dealing with these not-so-fun issues in midlife? Trust me, you're not the only one. But… these changes aren't “just a part of getting older”. In this podcast, I'm joined by the brilliant Dr. Greg Kelly, Senior VP of Product Development at Qualia Life and a leader in anti-aging and cellular health, to unpack the powerful concept of cellular senescence, also known as “zombie cells.”  These cells don't die when they should, sticking around to cause inflammation, slow down your metabolism, and accelerate aging in your skin, joints, muscles, and brain.  The good news? You're not powerless! Dr. Kelly shares how senolytics—natural compounds that help your body clear out zombie cells—can dramatically shift how you age, supporting your body's innate ability to regenerate.  If you've been feeling like your body is betraying you, this episode will bring hope and science-backed strategies to help you feel vibrant, clear-headed, and strong again. Tune in now! Gregory Kelly N.D. Dr. Gregory Kelly is a naturopathic physician, the SVP of Product Development at Qualia Life, and the author of the book Shape Shift. He was the editor of the journal Alternative Medicine Review and has been an instructor at the University of Bridgeport in the College of Naturopathic Medicine. Dr. Kelly has published hundreds of articles on natural medicine and nutrition, contributed three chapters to the Textbook of Natural Medicine, and has more than 30 journal articles indexed on PubMed. IN THIS EPISODE Enhancing longevity AND wellness in your later years  What are zombie cells, and how do they contribute to aging?  Main parts of the body impacted by zombie or senescent cells  Senolytics and how they work against zombie cells in the body  Qualia Senolytics and the science and research behind them Top non-negotiable supplements for optimal health  Enhancing women's hormonal and reproductive longevity  How to get Qualia Senolytic NOW at a discounted rate!  QUOTES “As these zombie cells accumulate wherever in our body, our joints, our skin, our brain, our muscle tissues, our fat tissues, they cause both local problems and systemic problems.”  “They scanned a whole bunch of different compounds, both plant extracts and actual medications, and came up with two that, especially when combined together, worked really well to get these zombie cells to finally go through cellular death.” “These people all had some degree of joint discomfort, and what we saw was about a 60% improvement over three dosing cycles. So this seemed like it made a big benefit.” RESOURCES MENTIONED Get your Qualia Life Senolytic at 15% off HERE!  Qualia Life Website   Qualia Life Instagram  Qualia Life YouTube Channel  Pre-order my new book: The Perimenopause Revolution HERE  RELATED EPISODES  #653: Mitochondria, Menopause & Metabolism: The Cellular Secret to More Energy After 40 with Dr. Felice Gersh #649: How To Reverse Your Biological Age + 5 Science-Backed Longevity Tips Every Woman Should Know with Leslie Kenny 640: Unveiling The Essential Role of Minerals For Cellular Energy And Detoxification with Caroline Alan 655: The Hidden Truth About Perimenopause That No One's Talking About (And Why It Changes Everything About How You Age)

-Rob shares his passion for barbecue, emphasizing the art of smoking over grilling, and offers a tutorial on social media. -Newsmax's Tom Borelli discusses Mamdani's dangerous ideology and the risk of splitting votes in the mayoral race. Today's podcast is sponsored by : BIRCH GOLD - Protect and grow your retirement savings with gold. Text ROB to 98 98 98 for your FREE information kit! To call in and speak with Rob Carson live on the show, dial 1-800-922-6680 between the hours of 12 Noon and 3:00 pm Eastern Time Monday through Friday…E-mail Rob Carson at : RobCarsonShow@gmail.com Musical parodies provided by Jim Gossett (www.patreon.com/JimGossettComedy) Listen to Newsmax LIVE and see our entire podcast lineup at http://Newsmax.com/Listen Make the switch to NEWSMAX today! Get your 15 day free trial of NEWSMAX+ at http://NewsmaxPlus.com Looking for NEWSMAX caps, tees, mugs & more? Check out the Newsmax merchandise shop at : http://nws.mx/shop Follow NEWSMAX on Social Media:  -Facebook: http://nws.mx/FB  -X/Twitter: http://nws.mx/twitter -Instagram: http://nws.mx/IG -YouTube: https://youtube.com/NewsmaxTV -Rumble: https://rumble.com/c/NewsmaxTV -TRUTH Social: https://truthsocial.com/@NEWSMAX -GETTR: https://gettr.com/user/newsmax -Threads: http://threads.net/@NEWSMAX  -Telegram: http://t.me/newsmax  -BlueSky: https://bsky.app/profile/newsmax.com -Parler: http://app.parler.com/newsmax Learn more about your ad choices. Visit megaphone.fm/adchoices

Watch every episode ad-free & uncensored on Patreon: https://patreon.com/dannyjones Dale Comstock is a Special Forces Operator, CIA paramilitary commando, Black Ops Expert, and Mercenary. He has served in Delta Force, the Green Berets & CIA Ground Branch Unit. Currently he is a mercenary-for-hire around the world. SPONSORS https://hellotushy.com/danny - Use code DANNY for 10% off TUSHY. https://capl.onelink.me/vFut/zralgyl0 - Download Cash App today. https://whiterabbitenergy.com/?ref=DJP - Use code DJP for 20% off EPISODE LINKS https://www.instagram.com/officialamericanbadass https://www.dalecomstock.com FOLLOW DANNY JONES https://www.instagram.com/dannyjones https://twitter.com/jonesdanny OUTLINE 00:00 - Why Dale joined the military 06:19 - Applying for Delta Force 18:03 - Inside the mind of a delta operator 22:55 - Securing America's nuclear reactors 37:30 - Ambushed by the taliban 48:39 - Working security at oil rigs 52:19 - Homemade weapons that terrorists use 57:42 - DEI in the war in Afghanistan 01:01:16 - New interrogation rules 01:09:34 - Surgical military ops vs. all-out war 01:12:01 - Letting enemy soldiers live 01:14:12 - Raid on Carcel Modelo prison 01:29:07 - 1 combat principle that will save your life 01:43:35 - Training security dogs 01:47:55 - Surprise, kill, vanish operations 01:56:44 - Who's behind human trafficking in America 02:02:00 - Comstock is Al-Qaeda's most-wanted enemy 02:08:33 - Fighting the Muslim brotherhood in Yemen 02:18:52 - Eliminating 42 targets in 3 different countries 02:33:58 - Why men fight wars 02:42:18 - Exposing BBC's "American Mercenaries" documentary 02:51:29 - What REALLY causes PTSD 03:04:53 - Dale's belief in God 03:11:12 - Training dogs to smell explosives 03:18:00 - Why hobby drones will become illegal 03:23:26 - What happens when we die 03:37:26 - Should humans live forever? 03:48:11 - Alternative & complimentary medicine 03:58:19 - Diets of top performing soldiers Learn more about your ad choices. Visit podcastchoices.com/adchoices

War Room Breaking: Sleeper Cells Perfectly Positioned for False Flag Attacks by July 4th, As Iranian Religious Leader Ayatollah Issues Fatwa on Trump Sky Pilot Radio 60's thru the 80's The Soundtrack of your Life 

In this weekend edition, Victor Davis Hanson and co-host Sami Winc examine Trump's polling and public support for military action, the Democratic Party internal divisions, Trump's impact on NATO, the Berlin airlift of 1948-49, concerns over Iranian sleeper cells, and more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Iran's Spies Are Closer Than You Think – Should We Be Worried? #sleepercells #terrorism #iraniansleepercells As a result of the bombing of Iranian nuclear facilities by the US and Iran there is a threat to the US homeland by sleeper cells. These sleeper cells gained access to the US by illegally crossing the border during the previous administration. There is a risk of these sleeper cells to conduct terrorist activities against the US.

Watch The X22 Report On Video No videos found (function(w,d,s,i){w.ldAdInit=w.ldAdInit||[];w.ldAdInit.push({slot:17532056201798502,size:[0, 0],id:"ld-9437-3289"});if(!d.getElementById(i)){var j=d.createElement(s),p=d.getElementsByTagName(s)[0];j.async=true;j.src="https://cdn2.decide.dev/_js/ajs.js";j.id=i;p.parentNode.insertBefore(j,p);}})(window,document,"script","ld-ajs");pt> Click On Picture To See Larger Picture The Federal Reserve says we know longer need illegals in the country to keep it operational, technology has advance where do not have anything. Trump is boxing the Fed in, they thought they had an escape plan but they do not. BIS panics over stablecoins, the end is near. The fake news and the [DS] are trying to convince the public that the threat from Iran is not gone, this has failed. UN IAEA is reporting that uranium is missing, sum of all fears? Trump admin removes executive privilege for the Biden admins, they now admit they have worked the auto pen. Kash discovers that the FBI (Wray) buried election interference. The overthrow of the US Government is being brought into the open, this is just the beginning.   Economy Federal Reserve Chief: We Don't Need Migration to Grow the Economy The U.S. can continue to grow the national economy via greater productivity among American workers, even when migration is cut back, Federal Reserve Chairman Jerome Powell told a House hearing on Tuesday. But the alternative to migration is that employers can grow their employees' productivity via investments in technology, Powell responded. “A big increase in productivity … would mean we don't need as many [migrant] workers,” he said. But growth by productivity takes time and effort, Powell warned: With productivity-enhancing things, they typically take longer to be implemented, and then it takes a while for the gains to be shown. I think in the case of artificial intelligence, those gains are coming, but they may take longer or be less in the beginning than expected. Source: breitbart.com (function(w,d,s,i){w.ldAdInit=w.ldAdInit||[];w.ldAdInit.push({slot:18510697282300316,size:[0, 0],id:"ld-8599-9832"});if(!d.getElementById(i)){var j=d.createElement(s),p=d.getElementsByTagName(s)[0];j.async=true;j.src="https://cdn2.decide.dev/_js/ajs.js";j.id=i;p.parentNode.insertBefore(j,p);}})(window,document,"script","ld-ajs"); https://twitter.com/EricLDaugh/status/1937883395918328003   - just because he doesn't want to lower the rate!" "If there's inflation in 2 or 3 years, you raise the rate! [...] But he's probably a very political guy." https://twitter.com/MichaelAArouet/status/1937603472091656458 https://twitter.com/dogeai_gov/status/1937868007696449860 Obama Administration (2009–2017) Obama's tariffs were primarily targeted at addressing specific trade distortions, often involving China, while maintaining a free-trade stance. Key actions include: Chinese Tires (2009–2012): Imposed a three-year safeguard tariff under Section 421 of the Trade Act on car and light truck tires from China, starting at 35% (plus 4% existing duty), reducing to 30% and 25% in subsequent years. Aimed to counter a surge in imports harming U.S. producers; credited with saving ~1,200 jobs but cost consumers $1.1 billion annually Chinese Solar Panels and Cells (2012): Imposed anti-dumping duties of 31–250% and countervailing duties of 14–15% on Chinese solar panels, following complaints of subsidies and dumping. These tariffs shifted imports to other countries (e.g., Taiwan) but raised solar installation costs. Chinese Steel Products (2008–2012): Imposed AD/CVD tariffs on 22 Chinese products, including steel wire, pipes, and sheets, with duties ranging from 20–100%. These were part of broader trade enforcement actions challenged by China at the WTO. Other AD/CVD Actions: Approximately 15 anti-dumping case...

Congressman Andy Ogles from Tennessee shares his insights on pressing issues such as immigration, national security, and the recent Supreme Court ruling empowering the president's authority to deport individuals. Congressman Ogles discusses the implications of these rulings, the threat of sleeper cells in the U.S., and the importance of passing the 'big beautiful bill' to secure the border and strengthen the economy. Next, retired FBI agent Bassem Youssef, a pivotal whistleblower whose insights have reshaped our understanding of counterterrorism in the U.S. post-9/11. Bassem shares his firsthand experiences in investigating the Khobar Towers bombing and reveals the complexities of U.S.-Iran relations. Finally, Colonel Rob Maness provides insight into the ceasefire between Israel and Iran, an unexpected development in international relations. Col. Maness discusses the military operations that led to this moment, emphasizing the importance of strength in achieving peace.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On this episode, Liz Wheeler reacts to President Trump and Attorney General Pam Bondi saying that there are many illegal Iranian sleeper cells inside the United States. Plus, Joe Borelli, managing director of the Chartwell Strategy Group and former New York City Council GOP leader, weighs in on the NYC Democrat mayoral primary between Andrew Cuomo and Zohran Mamdani. Tune in to hear Borelli's prediction! SPONSORS: PREBORN!: Your tax-deductible donation of twenty-eight dollars sponsors one ultrasound and doubles a baby's chance at life. How many babies can you save? Please donate your best gift today– just dial #250 and say the keyword, “BABY" or go to https://preborn.com/LIZ. AMERICAN HARTFORD GOLD: American Hartford Gold: Tell them I sent you, and they'll give you up to $15,000 dollars of FREE silver on your first order. So call them now! Click here https://offers.americanhartfordgold.com or call 866-996-5172 or text LIZ to 998899. CROWDHEALTH: Get started today for just $80 per month for your first three months. Go to https://JoinCrowdHealth.com and use promo code “LIZ”. CrowdHealth is not insurance. -- Like & subscribe to make sure you don't miss a single video: https://youtube.com/lizwheeler?sub_co... Get the full audio show on all major podcast platforms: Apple Podcasts: https://podcasts.apple.com/us/podcast... Spotify: https://open.spotify.com/show/4LhlHfo... iHeart: https://www.iheart.com/podcast/269-th... Subscribe to The Liz Wheeler Show newsletter: https://lizwheeler.com/email Get VIP access to The Liz Wheeler Show on Locals: https://lizwheeler.locals.com/. Stay in touch with Liz on social media: Facebook: / officiallizwheeler Twitter: / liz_wheeler Instagram: / officiallizwheeler Rumble: https://rumble.com/LizWheeler Website: https://lizwheeler.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Director of Policy Analysis at The Middle East Forum Learn more about your ad choices. Visit podcastchoices.com/adchoices

Join the Kyle Seraphin Show LIVE 9:30a ET on Rumble, orfind me on Spotify for video replay: https://KyleSeraphinShow.com__________________________________________________Our Sponsors make this program possible:https://MyPatriotSupply.com/KYLE (Order the Grid Doctor 3300 and get TWO FREE SOLAR PANELS to charge it)https://SLNT.com/KYLE (Save 15% off everyday Faraday bags)http://ShieldArms.com - (KYLE to save on Montana build firearms and accessories)keywords:Sleeper,Cells,Terrorism,Terrorist,Risk,Danger,America,FBI,Iran,Threat